In-vitro anti-sickling potential of baicalin and naringenin isolated from Oroxylum indicum and Citrus aurantium on human sickle red blood cells.

Autor: Lone, Bashir Ahmad, Sharma, Nitika, Kour, Dilpreet, Bhushan, Anil, Rani, Dixhiya, Kumar, Ajay, Gupta, Prashant Kumar, Gupta, Prasoon
Předmět:
Zdroj: Natural Product Research; Nov/Dec2023, Vol. 37 Issue 22, p3902-3908, 7p
Abstrakt: Sickle cell disease (SCD) is a rare inherited disorder in which red blood cells (RBCs) under oxidative stress have altered sickle shape resulting in clinical complications. In this study, a library of pure natural products were screened to see their effectiveness in preventing sickling induced in blood samples of SCA patients, ex-vivo. The results indicated that baicalin (1) and naringenin (2), reduced sickling by 46.03 and 37.48 percent, respectively, compared to positive control, 4-hydroxybenzoic acid (4-HBA), which inhibited RBC sickling by 56.87 percent. As a result of this screening, two compounds, baicalin (1) and naringenin (2), have been identified as potent sickling inhibitors. Study has clearly shown promising role of flavonoids for the management of SCD crisis for that not effective therapy is available. These phytochemicals or plant extracts can be explored further as an alternative anti-sickling remedy, owing to their high efficacy in the management of SCD crisis. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index